Ellis I - Search Results

1

Practice protocol: transition to community nursing practice revisited.

Ellis I, Chater K. Ellis I, et al. Contemp Nurse. 2012 Aug;42(1):90-6. doi: 10.5172/conu.2012.42.1.90. Contemp Nurse. 2012. PMID: 23050575

2

Studying the transition to maternal child health nurse.

Ellis I, Carr J, Gardiner M. Ellis I, et al. Aust Nurs J. 2009 Jul;17(1):40-1. Aust Nurs J. 2009. PMID: 19678490 No abstract available.

3

Protein Tyrosine Kinase 7 (PTK7) in Breast Cancer: A Retrospective Analysis of Tumour Expression and Association with Clinical Outcome.

Lacey K, Greener MR, Marak TR, Rakha EA, Green AR, Ellis IO, Martin SG, Storr SJ. Lacey K, et al. Among authors: ellis io. Cancers (Basel). 2024 Sep 20;16(18):3206. doi: 10.3390/cancers16183206. Cancers (Basel). 2024. PMID: 39335176 Free PMC article.

4

HER2-positive grade 1 invasive carcinomas of the breast.

Lee AHS, Hodi Z, Abbas A, Ellis IO, Rakha EA. Lee AHS, et al. Among authors: ellis io. Histopathology. 2024 Sep 11. doi: 10.1111/his.15315. Online ahead of print. Histopathology. 2024. PMID: 39257304

5

Effect of Mifepristone on Migration and Proliferation of Oral Cancer Cells.

Iftikhar A, Shepherd S, Jones S, Ellis I. Iftikhar A, et al. Among authors: ellis i. Int J Mol Sci. 2024 Aug 12;25(16):8777. doi: 10.3390/ijms25168777. Int J Mol Sci. 2024. PMID: 39201464 Free PMC article.

6

What factors influence cellular pathologists' confidence in case reporting?

Evans H, Kimani PK, Hiller L, Tsang YW, Sah S, Gopalakrishnan K, Boyd C, Loughrey MB, Kelly PJ, Boyle DP, Clark D, Ellis IO, Ilyas M, Rakha E, Bickers A, Roberts ISD, Soares MF, Neil DAH, Dunn JA, Azam A, Snead D. Evans H, et al. Among authors: ellis io. Virchows Arch. 2024 Aug 17. doi: 10.1007/s00428-024-03899-1. Online ahead of print. Virchows Arch. 2024. PMID: 39153110

7

Global Study on the Accuracy of Human Epidermal Growth Factor Receptor 2-Low Diagnosis in Breast Cancer.

Rüschoff J, Penner A, Ellis IO, Hammond MEH, Lebeau A, Osamura RY, Penault-Llorca F, Rojo F, Desai C, Moh A, Atkey N, Baenfer G, Scheel AH, D'Arrigo C, Schildhaus HU, Viale G; HER2-Low Study Group. Rüschoff J, et al. Among authors: ellis io. Arch Pathol Lab Med. 2024 Aug 8. doi: 10.5858/arpa.2024-0052-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 39111775 Free article.

8

Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy.

Masisi BK, El Ansari R, Alfarsi L, Fakroun A, Erkan B, Ibrahim A, Toss M, Ellis IO, Rakha EA, Green AR. Masisi BK, et al. Among authors: ellis io. Cancers (Basel). 2024 May 21;16(11):1949. doi: 10.3390/cancers16111949. Cancers (Basel). 2024. PMID: 38893070 Free PMC article.

9

Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation study.

Lashen AG, Toss M, Miligy I, Rewcastle E, Kiraz U, Janssen EAM, Green AR, Quinn C, Ellis I, Rakha EA. Lashen AG, et al. Among authors: ellis i. Histopathology. 2024 Sep;85(3):468-477. doi: 10.1111/his.15234. Epub 2024 Jun 13. Histopathology. 2024. PMID: 38867570

10

ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer.

Patel R, Alfarsi LH, El-Ansari R, Masisi BK, Erkan B, Fakroun A, Ellis IO, Rakha EA, Green AR. Patel R, et al. Among authors: ellis io. Pathobiology. 2024 Jun 11:1-11. doi: 10.1159/000539564. Online ahead of print. Pathobiology. 2024. PMID: 38861938 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,065 results

Search Page

Filters